MX2011011159A - Uso novedoso. - Google Patents

Uso novedoso.

Info

Publication number
MX2011011159A
MX2011011159A MX2011011159A MX2011011159A MX2011011159A MX 2011011159 A MX2011011159 A MX 2011011159A MX 2011011159 A MX2011011159 A MX 2011011159A MX 2011011159 A MX2011011159 A MX 2011011159A MX 2011011159 A MX2011011159 A MX 2011011159A
Authority
MX
Mexico
Prior art keywords
novel use
inflammatory disorder
galactooligosaccharide
prevention
treatment
Prior art date
Application number
MX2011011159A
Other languages
English (en)
Other versions
MX341308B (es
Inventor
Georgios Tzortzis
Jelena Vulevic
Francesco Attanasio
Original Assignee
Clasado Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40774842&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2011011159(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Clasado Inc filed Critical Clasado Inc
Publication of MX2011011159A publication Critical patent/MX2011011159A/es
Publication of MX341308B publication Critical patent/MX341308B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente invención se refiere al uso de un galactooligosacárido en la prevención o tratamiento de un trastorno inflamatorio, en particular un trastorno inflamatorio intestinal.
MX2011011159A 2009-04-23 2010-04-23 Método para prevenir inflamación. MX341308B (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0906983.2A GB0906983D0 (en) 2009-04-23 2009-04-23 Novel use
GBGB0920784.6A GB0920784D0 (en) 2009-04-23 2009-11-27 Novel use
PCT/GB2010/050659 WO2010122344A1 (en) 2009-04-23 2010-04-23 Novel use

Publications (2)

Publication Number Publication Date
MX2011011159A true MX2011011159A (es) 2011-11-07
MX341308B MX341308B (es) 2016-08-12

Family

ID=40774842

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2011011159A MX341308B (es) 2009-04-23 2010-04-23 Método para prevenir inflamación.

Country Status (25)

Country Link
US (1) US20120058972A1 (es)
EP (1) EP2421541B1 (es)
JP (1) JP2012524770A (es)
KR (1) KR20110138416A (es)
CN (1) CN102427818A (es)
AU (1) AU2010240642B2 (es)
BR (1) BRPI1015091A2 (es)
CA (1) CA2759442C (es)
CY (1) CY1120597T1 (es)
DK (1) DK2421541T3 (es)
ES (1) ES2688786T3 (es)
GB (3) GB0906983D0 (es)
HU (1) HUE040451T2 (es)
IL (1) IL215855A0 (es)
MX (1) MX341308B (es)
MY (1) MY151104A (es)
NZ (1) NZ595969A (es)
PL (1) PL2421541T3 (es)
PT (1) PT2421541T (es)
RU (1) RU2530567C2 (es)
SG (1) SG175313A1 (es)
TR (1) TR201810868T4 (es)
UA (1) UA106491C2 (es)
WO (1) WO2010122344A1 (es)
ZA (1) ZA201107821B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2492559B (en) * 2011-07-05 2018-07-25 Clasado Inc Composition and method for preventing or reducing the risk of developing a syndrome
EP2734210B1 (en) 2011-07-22 2017-11-22 Abbott Laboratories Galactooligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
CN103716787B (zh) 2012-09-29 2020-06-23 北京三星通信技术研究有限公司 一种支持对家用基站进行验证的方法
CN107158011A (zh) * 2017-05-25 2017-09-15 浙江大学 低聚半乳糖在制备治疗肠道疾病的药物中的用途
US20220218728A1 (en) * 2019-05-15 2022-07-14 N.V. Nutricia Beta-1,3'-galactosyllactose for the treatment of gut barrier function diseases
AU2022302375A1 (en) * 2021-07-01 2024-02-01 N.V. Nutricia Nutritonal compositions for gut barrier function
KR102453998B1 (ko) * 2022-01-07 2022-10-14 (주)네오크레마 갈락토올리고당을 포함하는 염증성 장질환의 예방, 개선 또는 치료용 조성물
GB2619977A (en) * 2022-06-24 2023-12-27 Clasado Res Services Limited Compositions and uses thereof
GB2623336A (en) * 2022-10-12 2024-04-17 Clasado Res Services Limited Compositions and uses thereof
GB2623335A (en) * 2022-10-12 2024-04-17 Clasado Res Services Limited Compositions and uses thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0229015D0 (en) * 2002-12-12 2003-01-15 Novartis Nutrition Ag New Compound
GB0315266D0 (en) * 2003-06-30 2003-08-06 Clasado Inc Novel galactooligosaccharide composition and the preparation thereof
PL1644482T5 (pl) * 2003-06-30 2015-05-29 Clasado Inc Nowa kompozycja galaktooligosacharydów i jej wytwarzanie
EP1597978A1 (en) 2004-05-17 2005-11-23 Nutricia N.V. Synergism of GOS and polyfructose
EP1887017A1 (en) * 2006-08-09 2008-02-13 Friesland Brands B.V. Prebiotic carbohydrate
GB0809921D0 (en) * 2008-05-30 2008-07-09 Clasado Inc Product and process therefor

Also Published As

Publication number Publication date
GB0906983D0 (en) 2009-06-03
KR20110138416A (ko) 2011-12-27
RU2011147390A (ru) 2013-05-27
AU2010240642A1 (en) 2011-11-10
GB201120030D0 (en) 2012-01-04
CA2759442A1 (en) 2010-10-28
WO2010122344A1 (en) 2010-10-28
US20120058972A1 (en) 2012-03-08
GB0920784D0 (en) 2010-01-13
EP2421541B1 (en) 2018-07-11
GB2482817B (en) 2014-02-26
CN102427818A (zh) 2012-04-25
RU2530567C2 (ru) 2014-10-10
PT2421541T (pt) 2018-10-15
AU2010240642B2 (en) 2013-03-14
UA106491C2 (uk) 2014-09-10
SG175313A1 (en) 2011-11-28
MY151104A (en) 2014-04-15
HUE040451T2 (hu) 2019-03-28
IL215855A0 (en) 2012-01-31
JP2012524770A (ja) 2012-10-18
DK2421541T3 (en) 2018-09-24
GB2482817A (en) 2012-02-15
EP2421541A1 (en) 2012-02-29
ZA201107821B (en) 2012-07-25
PL2421541T3 (pl) 2018-11-30
TR201810868T4 (tr) 2018-08-27
CA2759442C (en) 2016-01-19
NZ595969A (en) 2013-03-28
MX341308B (es) 2016-08-12
ES2688786T3 (es) 2018-11-06
BRPI1015091A2 (pt) 2016-04-26
CY1120597T1 (el) 2019-12-11

Similar Documents

Publication Publication Date Title
GB2482817A (en) Novel use
EA201270619A1 (ru) Применение бетанехола для лечения ксеростомии
SI2398785T1 (sl) Äśiĺ äśenje 1-(2-(2,4-dimetilfenilsulfanil)fenil)-piperazina
MX2011007930A (es) Conjugados de insulina cristalina.
AP2012006341A0 (en) Mounting of wear members.
WO2010023422A8 (en) Use of prebiotic galacto-oligosaccharides in the treatment of intestinal inflammation
MX2011014019A (es) Derivados de diazahomoadamantano y sus metodos de uso.
EP2585067A4 (en) COMPOUND FOR THE TREATMENT OF ENTEROVIRUS
MX2012002299A (es) Uso de cetoenoles ciclicos contra bacterias fitopatogenas.
MY156873A (en) Novel forms of a multicyclic compound
UA103197C2 (uk) Застосування ніфуртимоксу для лікування хвороб, спричинених трихомонадами
UA96476C2 (ru) Фармацевтические композиции, которые содержат ирбесартан
MY173722A (en) Oligosaccharides composition for preventing or reducing the risk of metabolic syndrome
GB201013898D0 (en) Well treatment
MX2010004814A (es) Metodos para tratar esclerodermia.
IN2012DN01846A (es)
AP2011005893A0 (en) Thia-triaza-cyclopentazulenes as P13-kinases inhibitors for the treatment of cancer.
MX2012012509A (es) Tapentadol para usarse en el tratamiento del sindrome del intestino irritable.
UA42812U (ru) Использование мази тиотриазолина в качестве агента, обладающего фотопротекторными свойствами
AU4161P (en) MajesticPearl Prunus persica var. nucipersica
UA41922U (ru) Применение альтана как вещества с противолучевыми свойствами
UA96060C2 (ru) Применение липофлавона как средства фригопротекторного действия
AU2009275V (en) Royalruby Prunus persica var. nucipersica
UA94339C2 (ru) применение корвитина в качестве средства фригопротекторного действия
TN2010000463A1 (en) Compositions and methods for preparing and using same

Legal Events

Date Code Title Description
FG Grant or registration